The EUROPEAN JOURNAL OF OPHTHALMOLOGY, published by SAGE PUBLICATIONS LTD, is a leading international journal in the field of ophthalmology, dedicated to advancing the understanding and treatment of ocular diseases and disorders. With an ISSN of 1120-6721 and an E-ISSN of 1724-6016, the journal aims to provide a platform for innovative research, critical reviews, and comprehensive studies that span the diverse aspects of the discipline. As part of its commitment to disseminating high-quality research, the journal is indexed in Scopus, achieving an impressive rank of #47 out of 137 in the Medicine - Ophthalmology category, indicating its strong impact within the academic community. With a current impact factor that places it in the Q2 quartile for both Medicine (miscellaneous) and Ophthalmology as of 2023, it offers researchers and practitioners access to important findings and developments in eye health. The journal's converged years from 1991 to 2024 exemplify its longstanding commitment to the field, making it an essential resource for anyone looking to stay at the forefront of ophthalmological research.

RETINA - THE JOURNAL OF RETINAL AND VITREOUS DISEASES is a premier peer-reviewed journal dedicated to advancing the knowledge and practice of retinal and vitreous disorders. Published by LIPPINCOTT WILLIAMS & WILKINS, this esteemed journal boasts a significant impact factor, affirming its standing in the academic community. With a long history of publication since 1981, its scope covers cutting-edge research and innovations aimed at improving patient outcomes in ophthalmology. As evidenced by its recent categorization in the Q1 quartile for both Medicine (miscellaneous) and Ophthalmology in 2023, the journal ranks impressively, placing it in the 84th percentile among its peers. Researchers, clinicians, and students will find valuable insights and evidence-based articles that contribute to the ever-evolving landscape of retinal health. RETINA remains committed to fostering an environment for scholarly dialogue and dissemination of knowledge, ensuring its readers are at the forefront of advancements in their field.

OPHTHALMOLOGICA is a prestigious journal published by KARGER, dedicated to the dynamic field of ophthalmology and its interdisciplinary connections with medicine and sensory systems. With a rich history spanning over a century since its inception in 1899, this journal is esteemed for its high-quality research and impactful contributions, maintaining an impressive Q1 quartile ranking in both ophthalmology and miscellaneous medicine as of 2023, alongside a notable Q2 status in sensory systems. The journal's influence is reinforced by its Scopus rankings, where it ranks 26th out of 137 in ophthalmology, showcasing a strong percentile position of 81. Based in Basel, Switzerland, OPHTHALMOLOGICA serves as an essential platform for researchers, professionals, and students, providing essential insights, reviews, and studies that push the boundaries of knowledge in the vision sciences. Although it does not currently offer open access, its contributions are critical for those pursuing advancements in ocular health and related disciplines.

Ophthalmology and Therapy is a premier open-access journal published by Springer International Publishing AG, dedicated to advancing the field of ophthalmology through innovative research and clinical studies. With an ISSN of 2193-8245 and an E-ISSN of 2193-6528, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the latest developments in eye care and vision science. The journal has achieved a remarkable impact factor and has been recognized as a Q1 journal in Ophthalmology, reflecting its contributions to the discipline and its high-quality publications. Operating from the United Kingdom, Ophthalmology and Therapy is an open-access platform that has been available since 2012, ensuring that critical research is accessible to a global audience. Its commitment to fostering collaboration and knowledge sharing is exemplified by its ranking of #39 out of 137 in the Scopus category for Medicine – Ophthalmology, placing it in the 71st percentile of its peers. Together, these attributes highlight the journal's importance as a key forum for the dissemination of cutting-edge research, making it an essential addition to the libraries of institutions and professionals engaged in ophthalmic care.

Ophthalmology Science is a premier journal published by Elsevier, dedicated to advancing the field of ophthalmology through innovative research and clinical insights. With an impact factor that positions it in the Q1 category of ophthalmology journals, it stands out as a crucial resource for researchers, clinicians, and students alike. The journal, indexed under ISSN 2666-9145, covers a wide array of topics relevant to eye care, encompassing the latest breakthroughs in diagnostics, therapeutics, and surgical techniques. Operating in the United States from its office in Amsterdam, the journal aims to bridge the gap between laboratory findings and clinical applications, contributing to improved patient outcomes globally. The converged years from 2021 to 2024 reflect its commitment to providing timely and impactful research that shapes the future of ophthalmic practice. Make sure to explore the open access options available for wider dissemination of your work and to stay ahead in the evolving landscape of ophthalmology.

The Journal of Ophthalmology, published by HINDAWI LTD, is an esteemed open-access journal that has been disseminating significant research in the field of ophthalmology since 2009. With an ISSN of 2090-004X and an E-ISSN of 2090-0058, this journal facilitates global access to cutting-edge studies, making it an essential resource for researchers, clinicians, and students alike. Ranked in the Q2 category of ophthalmology for 2023, the journal holds a commendable position with a Scopus rank of #37 out of 137 in its field, placing it in the 73rd percentile. The journal encompasses a variety of topics such as clinical advancements, surgical techniques, and innovative technologies in eye care, aiming to advance scientific knowledge and clinical practice in ophthalmology. By providing a platform for both novel research and comprehensive reviews, the Journal of Ophthalmology is instrumental in fostering collaboration and scholarly communication within the global eye health community, and its commitment to open access ensures that impactful research reaches a wide audience without barriers.

EXPERIMENTAL EYE RESEARCH, published by Academic Press Ltd - Elsevier Science Ltd, is a preeminent journal dedicated to advancing the fields of ophthalmology and neuroscience. With a history of insightful publications dating back to 1961, this journal serves as a critical platform for researchers, professionals, and students interested in the cellular and molecular mechanisms underlying visual processes. The journal boasts impressive rankings, including being placed in the top quartile (Q1) of both the Ophthalmology and Sensory Systems categories, and is recognized in the 2nd quartile (Q2) for Cellular and Molecular Neuroscience. With an impact factor reflecting its significant contribution to the field, EXPERIMENTAL EYE RESEARCH is a valuable resource that promotes the exchange of innovative research and ideas essential for understanding the complexities of eye function and vision-related disorders. Researchers looking to publish their findings or stay abreast of the latest studies will find this journal a vital component of their academic toolkit.

CURRENT EYE RESEARCH is a prestigious academic journal published by Taylor & Francis Inc, focusing on advancing the field of ophthalmology and its intersection with cellular and molecular neuroscience. Since its inception in 1981, this journal has provided a vital platform for original research, reviews, and technical notes, presenting a wealth of knowledge to practitioners and researchers alike. With an impressive 2023 impact factor reflected in its ranking of Q2 in Ophthalmology and Q2 in Sensory Systems, and a Q3 ranking in Cellular and Molecular Neuroscience, CURRENT EYE RESEARCH plays a crucial role in fostering interdisciplinary collaboration and innovation. The journal is indexed in Scopus, where it holds strong positions in both the Medicine and Neuroscience categories, enhancing its visibility and reach. Researchers and professionals in these fields can access cutting-edge findings and contribute to the ongoing discourse surrounding eye health, making it an essential resource for anyone invested in advancing knowledge and treatment in ophthalmic science.

Augenheilkunde Up2date is a pivotal journal in the field of ophthalmology, published by GEORG THIEME VERLAG KG, a renowned publisher known for its commitment to advancing medical knowledge. With its ISSN 1616-9719 and E-ISSN 1616-9735, this journal serves as a vital resource for researchers, professionals, and students interested in the latest developments and nuanced discussions in eye health. Although not available as open access, its curated content offers significant insights into contemporary research, clinical practices, and emerging trends in ophthalmology, thus promoting the continuous professional development of its readers. There is an emphasis on providing comprehensive reviews that encapsulate the pertinent advancements in the field, making it an essential publication for those aiming to enhance their expertise in eye care and vision science.

Turk Oftalmoloji Dergisi - Turkish Journal of Ophthalmology is a premier peer-reviewed publication dedicated to the field of ophthalmology, published by GALENOS PUBL HOUSE. Since its inception in 1997, this Open Access journal has championed the dissemination of high-quality research, fostering an inclusive environment for sharing knowledge and advancements in eye health. With an ISSN of 1300-0659 and an E-ISSN of 2147-2661, the journal serves as a vital resource for researchers, clinicians, and students interested in the latest findings and innovations in ophthalmic sciences. Although its coverage in Scopus has been discontinued since 2017, the journal has garnered a significant rank of 80 out of 114 in the field of Medicine – Ophthalmology, highlighting its relevance and impact within the discipline. Operating out of Istanbul, Turkey, the Turkish Journal of Ophthalmology continues to be a crucial platform for ophthalmologists and researchers to publish their work and advance the understanding of ocular health.